June 5, 2020

RECOVERY trial hydroxychloroquine update

Journalists joined Professor Peter Horby and Professor Martin Landray, Chief Investigators of the RECOVERY trial who provided results on the use of hydroxychloroquine as a potential treatment for patients hospitalised with COVID-19.

Speakers included:

Prof Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine, University of Oxford and Chief Investigator of the RECOVERY trial

Prof Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health, University of Oxford and Deputy Chief Investigator of the RECOVERY trial

An SMC Roundup accompanied this briefing.